These emerging therapies , Semaglutide , represent a significant advancement in managing obesity and potentially associated disorders. They all are classified as GLP-1 receptor stimulators, meaning they to emulate the body's GLP-1 peptide, stimulating metabolic release and reducing food intake. Although Tirzepatide every functions somewhat simil… Read More